Androstenedione Industry Research Report 2024
Summary
Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.
Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.
In the report, the data bases on androstenedione and androstadienedione.
According to APO Research, the global Androstenedione market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Androstenedione is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Androstenedione is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Androstenedione is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Androstenedione include BIOVET, Indo Phyto Chemicals, Sito Bio, Goto Pharmaceutical, Tianjin King York, Jiufu, Yongning Pharma, Jiangxi Hongyuan Pharmaceutical and Kaizon, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Androstenedione, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androstenedione.
The report will help the Androstenedione manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Androstenedione market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Androstenedione market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androstenedione market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Androstenedione and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androstenedione.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Androstenedione manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Androstenedione by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Androstenedione in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.
Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.
In the report, the data bases on androstenedione and androstadienedione.
According to APO Research, the global Androstenedione market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Androstenedione is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Androstenedione is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Androstenedione is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Androstenedione include BIOVET, Indo Phyto Chemicals, Sito Bio, Goto Pharmaceutical, Tianjin King York, Jiufu, Yongning Pharma, Jiangxi Hongyuan Pharmaceutical and Kaizon, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Androstenedione, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androstenedione.
The report will help the Androstenedione manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Androstenedione market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Androstenedione market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- BIOVET
- Indo Phyto Chemicals
- Sito Bio
- Goto Pharmaceutical
- Tianjin King York
- Jiufu
- Yongning Pharma
- Jiangxi Hongyuan Pharmaceutical
- Kaizon
- Xi’an Gaoyuan Bio-Chem
- Dongyao Pharmaceutical
- Huazhong Pharmaceutical
- Darui
- Danjiangkou Danao
- Dahua Pharmaceutical
- Androstenedione
- Androstadienedione
- Arthritis Pharmaceuticals
- Fertility Control Pharmaceuticals
- Infectious Inflammation Pharmaceuticals
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androstenedione market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Androstenedione and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androstenedione.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Androstenedione manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Androstenedione by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Androstenedione in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Androstenedione Market Size (2019-2030) & (US$ Million)
2.2.2 Global Androstenedione Sales (2019-2030)
2.2.3 Global Androstenedione Market Average Price (2019-2030)
2.3 Androstenedione by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Androstenedione
2.3.3 Androstadienedione
2.4 Androstenedione by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Arthritis Pharmaceuticals
2.4.3 Fertility Control Pharmaceuticals
2.4.4 Infectious Inflammation Pharmaceuticals
2.4.5 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Androstenedione Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Androstenedione Sales (MT) of Manufacturers (2019-2024)
3.3 Global Androstenedione Revenue of Manufacturers (2019-2024)
3.4 Global Androstenedione Average Price by Manufacturers (2019-2024)
3.5 Global Androstenedione Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Androstenedione, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Androstenedione, Product Type & Application
3.8 Global Manufacturers of Androstenedione, Date of Enter into This Industry
3.9 Global Androstenedione Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 BIOVET
4.1.1 BIOVET Company Information
4.1.2 BIOVET Business Overview
4.1.3 BIOVET Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.1.4 BIOVET Androstenedione Product Portfolio
4.1.5 BIOVET Recent Developments
4.2 Indo Phyto Chemicals
4.2.1 Indo Phyto Chemicals Company Information
4.2.2 Indo Phyto Chemicals Business Overview
4.2.3 Indo Phyto Chemicals Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Indo Phyto Chemicals Androstenedione Product Portfolio
4.2.5 Indo Phyto Chemicals Recent Developments
4.3 Sito Bio
4.3.1 Sito Bio Company Information
4.3.2 Sito Bio Business Overview
4.3.3 Sito Bio Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Sito Bio Androstenedione Product Portfolio
4.3.5 Sito Bio Recent Developments
4.4 Goto Pharmaceutical
4.4.1 Goto Pharmaceutical Company Information
4.4.2 Goto Pharmaceutical Business Overview
4.4.3 Goto Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Goto Pharmaceutical Androstenedione Product Portfolio
4.4.5 Goto Pharmaceutical Recent Developments
4.5 Tianjin King York
4.5.1 Tianjin King York Company Information
4.5.2 Tianjin King York Business Overview
4.5.3 Tianjin King York Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Tianjin King York Androstenedione Product Portfolio
4.5.5 Tianjin King York Recent Developments
4.6 Jiufu
4.6.1 Jiufu Company Information
4.6.2 Jiufu Business Overview
4.6.3 Jiufu Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Jiufu Androstenedione Product Portfolio
4.6.5 Jiufu Recent Developments
4.7 Yongning Pharma
4.7.1 Yongning Pharma Company Information
4.7.2 Yongning Pharma Business Overview
4.7.3 Yongning Pharma Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Yongning Pharma Androstenedione Product Portfolio
4.7.5 Yongning Pharma Recent Developments
4.8 Jiangxi Hongyuan Pharmaceutical
4.8.1 Jiangxi Hongyuan Pharmaceutical Company Information
4.8.2 Jiangxi Hongyuan Pharmaceutical Business Overview
4.8.3 Jiangxi Hongyuan Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolio
4.8.5 Jiangxi Hongyuan Pharmaceutical Recent Developments
4.9 Kaizon
4.9.1 Kaizon Company Information
4.9.2 Kaizon Business Overview
4.9.3 Kaizon Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Kaizon Androstenedione Product Portfolio
4.9.5 Kaizon Recent Developments
4.10 Xi’an Gaoyuan Bio-Chem
4.10.1 Xi’an Gaoyuan Bio-Chem Company Information
4.10.2 Xi’an Gaoyuan Bio-Chem Business Overview
4.10.3 Xi’an Gaoyuan Bio-Chem Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolio
4.10.5 Xi’an Gaoyuan Bio-Chem Recent Developments
4.11 Dongyao Pharmaceutical
4.11.1 Dongyao Pharmaceutical Company Information
4.11.2 Dongyao Pharmaceutical Business Overview
4.11.3 Dongyao Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Dongyao Pharmaceutical Androstenedione Product Portfolio
4.11.5 Dongyao Pharmaceutical Recent Developments
4.12 Huazhong Pharmaceutical
4.12.1 Huazhong Pharmaceutical Company Information
4.12.2 Huazhong Pharmaceutical Business Overview
4.12.3 Huazhong Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Huazhong Pharmaceutical Androstenedione Product Portfolio
4.12.5 Huazhong Pharmaceutical Recent Developments
4.13 Darui
4.13.1 Darui Company Information
4.13.2 Darui Business Overview
4.13.3 Darui Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Darui Androstenedione Product Portfolio
4.13.5 Darui Recent Developments
4.14 Danjiangkou Danao
4.14.1 Danjiangkou Danao Company Information
4.14.2 Danjiangkou Danao Business Overview
4.14.3 Danjiangkou Danao Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Danjiangkou Danao Androstenedione Product Portfolio
4.14.5 Danjiangkou Danao Recent Developments
4.15 Dahua Pharmaceutical
4.15.1 Dahua Pharmaceutical Company Information
4.15.2 Dahua Pharmaceutical Business Overview
4.15.3 Dahua Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Dahua Pharmaceutical Androstenedione Product Portfolio
4.15.5 Dahua Pharmaceutical Recent Developments
5 GLOBAL ANDROSTENEDIONE MARKET SCENARIO BY REGION
5.1 Global Androstenedione Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Androstenedione Sales by Region: 2019-2030
5.2.1 Global Androstenedione Sales by Region: 2019-2024
5.2.2 Global Androstenedione Sales by Region: 2025-2030
5.3 Global Androstenedione Revenue by Region: 2019-2030
5.3.1 Global Androstenedione Revenue by Region: 2019-2024
5.3.2 Global Androstenedione Revenue by Region: 2025-2030
5.4 North America Androstenedione Market Facts & Figures by Country
5.4.1 North America Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Androstenedione Sales by Country (2019-2030)
5.4.3 North America Androstenedione Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Androstenedione Market Facts & Figures by Country
5.5.1 Europe Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Androstenedione Sales by Country (2019-2030)
5.5.3 Europe Androstenedione Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Androstenedione Market Facts & Figures by Country
5.6.1 Asia Pacific Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Androstenedione Sales by Country (2019-2030)
5.6.3 Asia Pacific Androstenedione Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Androstenedione Market Facts & Figures by Country
5.7.1 Latin America Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Androstenedione Sales by Country (2019-2030)
5.7.3 Latin America Androstenedione Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Androstenedione Market Facts & Figures by Country
5.8.1 Middle East and Africa Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Androstenedione Sales by Country (2019-2030)
5.8.3 Middle East and Africa Androstenedione Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Androstenedione Sales by Type (2019-2030)
6.1.1 Global Androstenedione Sales by Type (2019-2030) & (MT)
6.1.2 Global Androstenedione Sales Market Share by Type (2019-2030)
6.2 Global Androstenedione Revenue by Type (2019-2030)
6.2.1 Global Androstenedione Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Androstenedione Revenue Market Share by Type (2019-2030)
6.3 Global Androstenedione Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Androstenedione Sales by Application (2019-2030)
7.1.1 Global Androstenedione Sales by Application (2019-2030) & (MT)
7.1.2 Global Androstenedione Sales Market Share by Application (2019-2030)
7.2 Global Androstenedione Revenue by Application (2019-2030)
7.2.1 Global Androstenedione Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Androstenedione Revenue Market Share by Application (2019-2030)
7.3 Global Androstenedione Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Androstenedione Value Chain Analysis
8.1.1 Androstenedione Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Androstenedione Production Mode & Process
8.2 Androstenedione Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Androstenedione Distributors
8.2.3 Androstenedione Customers
9 GLOBAL ANDROSTENEDIONE ANALYZING MARKET DYNAMICS
9.1 Androstenedione Industry Trends
9.2 Androstenedione Industry Drivers
9.3 Androstenedione Industry Opportunities and Challenges
9.4 Androstenedione Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Androstenedione Market Size (2019-2030) & (US$ Million)
2.2.2 Global Androstenedione Sales (2019-2030)
2.2.3 Global Androstenedione Market Average Price (2019-2030)
2.3 Androstenedione by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Androstenedione
2.3.3 Androstadienedione
2.4 Androstenedione by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Arthritis Pharmaceuticals
2.4.3 Fertility Control Pharmaceuticals
2.4.4 Infectious Inflammation Pharmaceuticals
2.4.5 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Androstenedione Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Androstenedione Sales (MT) of Manufacturers (2019-2024)
3.3 Global Androstenedione Revenue of Manufacturers (2019-2024)
3.4 Global Androstenedione Average Price by Manufacturers (2019-2024)
3.5 Global Androstenedione Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Androstenedione, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Androstenedione, Product Type & Application
3.8 Global Manufacturers of Androstenedione, Date of Enter into This Industry
3.9 Global Androstenedione Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 BIOVET
4.1.1 BIOVET Company Information
4.1.2 BIOVET Business Overview
4.1.3 BIOVET Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.1.4 BIOVET Androstenedione Product Portfolio
4.1.5 BIOVET Recent Developments
4.2 Indo Phyto Chemicals
4.2.1 Indo Phyto Chemicals Company Information
4.2.2 Indo Phyto Chemicals Business Overview
4.2.3 Indo Phyto Chemicals Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Indo Phyto Chemicals Androstenedione Product Portfolio
4.2.5 Indo Phyto Chemicals Recent Developments
4.3 Sito Bio
4.3.1 Sito Bio Company Information
4.3.2 Sito Bio Business Overview
4.3.3 Sito Bio Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Sito Bio Androstenedione Product Portfolio
4.3.5 Sito Bio Recent Developments
4.4 Goto Pharmaceutical
4.4.1 Goto Pharmaceutical Company Information
4.4.2 Goto Pharmaceutical Business Overview
4.4.3 Goto Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Goto Pharmaceutical Androstenedione Product Portfolio
4.4.5 Goto Pharmaceutical Recent Developments
4.5 Tianjin King York
4.5.1 Tianjin King York Company Information
4.5.2 Tianjin King York Business Overview
4.5.3 Tianjin King York Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Tianjin King York Androstenedione Product Portfolio
4.5.5 Tianjin King York Recent Developments
4.6 Jiufu
4.6.1 Jiufu Company Information
4.6.2 Jiufu Business Overview
4.6.3 Jiufu Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Jiufu Androstenedione Product Portfolio
4.6.5 Jiufu Recent Developments
4.7 Yongning Pharma
4.7.1 Yongning Pharma Company Information
4.7.2 Yongning Pharma Business Overview
4.7.3 Yongning Pharma Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Yongning Pharma Androstenedione Product Portfolio
4.7.5 Yongning Pharma Recent Developments
4.8 Jiangxi Hongyuan Pharmaceutical
4.8.1 Jiangxi Hongyuan Pharmaceutical Company Information
4.8.2 Jiangxi Hongyuan Pharmaceutical Business Overview
4.8.3 Jiangxi Hongyuan Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolio
4.8.5 Jiangxi Hongyuan Pharmaceutical Recent Developments
4.9 Kaizon
4.9.1 Kaizon Company Information
4.9.2 Kaizon Business Overview
4.9.3 Kaizon Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Kaizon Androstenedione Product Portfolio
4.9.5 Kaizon Recent Developments
4.10 Xi’an Gaoyuan Bio-Chem
4.10.1 Xi’an Gaoyuan Bio-Chem Company Information
4.10.2 Xi’an Gaoyuan Bio-Chem Business Overview
4.10.3 Xi’an Gaoyuan Bio-Chem Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolio
4.10.5 Xi’an Gaoyuan Bio-Chem Recent Developments
4.11 Dongyao Pharmaceutical
4.11.1 Dongyao Pharmaceutical Company Information
4.11.2 Dongyao Pharmaceutical Business Overview
4.11.3 Dongyao Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Dongyao Pharmaceutical Androstenedione Product Portfolio
4.11.5 Dongyao Pharmaceutical Recent Developments
4.12 Huazhong Pharmaceutical
4.12.1 Huazhong Pharmaceutical Company Information
4.12.2 Huazhong Pharmaceutical Business Overview
4.12.3 Huazhong Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Huazhong Pharmaceutical Androstenedione Product Portfolio
4.12.5 Huazhong Pharmaceutical Recent Developments
4.13 Darui
4.13.1 Darui Company Information
4.13.2 Darui Business Overview
4.13.3 Darui Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Darui Androstenedione Product Portfolio
4.13.5 Darui Recent Developments
4.14 Danjiangkou Danao
4.14.1 Danjiangkou Danao Company Information
4.14.2 Danjiangkou Danao Business Overview
4.14.3 Danjiangkou Danao Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Danjiangkou Danao Androstenedione Product Portfolio
4.14.5 Danjiangkou Danao Recent Developments
4.15 Dahua Pharmaceutical
4.15.1 Dahua Pharmaceutical Company Information
4.15.2 Dahua Pharmaceutical Business Overview
4.15.3 Dahua Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Dahua Pharmaceutical Androstenedione Product Portfolio
4.15.5 Dahua Pharmaceutical Recent Developments
5 GLOBAL ANDROSTENEDIONE MARKET SCENARIO BY REGION
5.1 Global Androstenedione Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Androstenedione Sales by Region: 2019-2030
5.2.1 Global Androstenedione Sales by Region: 2019-2024
5.2.2 Global Androstenedione Sales by Region: 2025-2030
5.3 Global Androstenedione Revenue by Region: 2019-2030
5.3.1 Global Androstenedione Revenue by Region: 2019-2024
5.3.2 Global Androstenedione Revenue by Region: 2025-2030
5.4 North America Androstenedione Market Facts & Figures by Country
5.4.1 North America Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Androstenedione Sales by Country (2019-2030)
5.4.3 North America Androstenedione Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Androstenedione Market Facts & Figures by Country
5.5.1 Europe Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Androstenedione Sales by Country (2019-2030)
5.5.3 Europe Androstenedione Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Androstenedione Market Facts & Figures by Country
5.6.1 Asia Pacific Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Androstenedione Sales by Country (2019-2030)
5.6.3 Asia Pacific Androstenedione Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Androstenedione Market Facts & Figures by Country
5.7.1 Latin America Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Androstenedione Sales by Country (2019-2030)
5.7.3 Latin America Androstenedione Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Androstenedione Market Facts & Figures by Country
5.8.1 Middle East and Africa Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Androstenedione Sales by Country (2019-2030)
5.8.3 Middle East and Africa Androstenedione Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Androstenedione Sales by Type (2019-2030)
6.1.1 Global Androstenedione Sales by Type (2019-2030) & (MT)
6.1.2 Global Androstenedione Sales Market Share by Type (2019-2030)
6.2 Global Androstenedione Revenue by Type (2019-2030)
6.2.1 Global Androstenedione Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Androstenedione Revenue Market Share by Type (2019-2030)
6.3 Global Androstenedione Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Androstenedione Sales by Application (2019-2030)
7.1.1 Global Androstenedione Sales by Application (2019-2030) & (MT)
7.1.2 Global Androstenedione Sales Market Share by Application (2019-2030)
7.2 Global Androstenedione Revenue by Application (2019-2030)
7.2.1 Global Androstenedione Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Androstenedione Revenue Market Share by Application (2019-2030)
7.3 Global Androstenedione Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Androstenedione Value Chain Analysis
8.1.1 Androstenedione Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Androstenedione Production Mode & Process
8.2 Androstenedione Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Androstenedione Distributors
8.2.3 Androstenedione Customers
9 GLOBAL ANDROSTENEDIONE ANALYZING MARKET DYNAMICS
9.1 Androstenedione Industry Trends
9.2 Androstenedione Industry Drivers
9.3 Androstenedione Industry Opportunities and Challenges
9.4 Androstenedione Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Androstenedione Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Androstenedione Sales (MT) of Manufacturers (2018-2023)
Table 7. Global Androstenedione Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Androstenedione Revenue of Manufacturers (2018-2023)
Table 9. Global Androstenedione Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Androstenedione Average Price (USD/MT) of Manufacturers (2018-2023)
Table 11. Global Androstenedione Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Androstenedione, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Androstenedione by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. BIOVET Company Information
Table 17. BIOVET Business Overview
Table 18. BIOVET Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 19. BIOVET Androstenedione Product Portfolio
Table 20. BIOVET Recent Developments
Table 21. Indo Phyto Chemicals Company Information
Table 22. Indo Phyto Chemicals Business Overview
Table 23. Indo Phyto Chemicals Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 24. Indo Phyto Chemicals Androstenedione Product Portfolio
Table 25. Indo Phyto Chemicals Recent Developments
Table 26. Sito Bio Company Information
Table 27. Sito Bio Business Overview
Table 28. Sito Bio Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 29. Sito Bio Androstenedione Product Portfolio
Table 30. Sito Bio Recent Developments
Table 31. Goto Pharmaceutical Company Information
Table 32. Goto Pharmaceutical Business Overview
Table 33. Goto Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 34. Goto Pharmaceutical Androstenedione Product Portfolio
Table 35. Goto Pharmaceutical Recent Developments
Table 36. Tianjin King York Company Information
Table 37. Tianjin King York Business Overview
Table 38. Tianjin King York Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 39. Tianjin King York Androstenedione Product Portfolio
Table 40. Tianjin King York Recent Developments
Table 41. Jiufu Company Information
Table 42. Jiufu Business Overview
Table 43. Jiufu Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 44. Jiufu Androstenedione Product Portfolio
Table 45. Jiufu Recent Developments
Table 46. Yongning Pharma Company Information
Table 47. Yongning Pharma Business Overview
Table 48. Yongning Pharma Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 49. Yongning Pharma Androstenedione Product Portfolio
Table 50. Yongning Pharma Recent Developments
Table 51. Jiangxi Hongyuan Pharmaceutical Company Information
Table 52. Jiangxi Hongyuan Pharmaceutical Business Overview
Table 53. Jiangxi Hongyuan Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 54. Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolio
Table 55. Jiangxi Hongyuan Pharmaceutical Recent Developments
Table 56. Kaizon Company Information
Table 57. Kaizon Business Overview
Table 58. Kaizon Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Kaizon Androstenedione Product Portfolio
Table 60. Kaizon Recent Developments
Table 61. Xi’an Gaoyuan Bio-Chem Company Information
Table 62. Xi’an Gaoyuan Bio-Chem Business Overview
Table 63. Xi’an Gaoyuan Bio-Chem Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 64. Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolio
Table 65. Xi’an Gaoyuan Bio-Chem Recent Developments
Table 66. Dongyao Pharmaceutical Company Information
Table 67. Dongyao Pharmaceutical Business Overview
Table 68. Dongyao Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 69. Dongyao Pharmaceutical Androstenedione Product Portfolio
Table 70. Dongyao Pharmaceutical Recent Developments
Table 71. Huazhong Pharmaceutical Company Information
Table 72. Huazhong Pharmaceutical Business Overview
Table 73. Huazhong Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 74. Huazhong Pharmaceutical Androstenedione Product Portfolio
Table 75. Huazhong Pharmaceutical Recent Developments
Table 76. Darui Company Information
Table 77. Darui Business Overview
Table 78. Darui Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 79. Darui Androstenedione Product Portfolio
Table 80. Darui Recent Developments
Table 81. Danjiangkou Danao Company Information
Table 82. Danjiangkou Danao Business Overview
Table 83. Danjiangkou Danao Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 84. Danjiangkou Danao Androstenedione Product Portfolio
Table 85. Danjiangkou Danao Recent Developments
Table 86. Dahua Pharmaceutical Company Information
Table 87. Dahua Pharmaceutical Business Overview
Table 88. Dahua Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 89. Dahua Pharmaceutical Androstenedione Product Portfolio
Table 90. Dahua Pharmaceutical Recent Developments
Table 91. Global Androstenedione Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 92. Global Androstenedione Sales by Region (2018-2023) & (MT)
Table 93. Global Androstenedione Sales Market Share by Region (2018-2023)
Table 94. Global Androstenedione Sales by Region (2024-2029) & (MT)
Table 95. Global Androstenedione Sales Market Share by Region (2024-2029)
Table 96. Global Androstenedione Revenue by Region (2018-2023) & (US$ Million)
Table 97. Global Androstenedione Revenue Market Share by Region (2018-2023)
Table 98. Global Androstenedione Revenue by Region (2024-2029) & (US$ Million)
Table 99. Global Androstenedione Revenue Market Share by Region (2024-2029)
Table 100. North America Androstenedione Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. North America Androstenedione Sales by Country (2018-2023) & (MT)
Table 102. North America Androstenedione Sales by Country (2024-2029) & (MT)
Table 103. North America Androstenedione Revenue by Country (2018-2023) & (US$ Million)
Table 104. North America Androstenedione Revenue by Country (2024-2029) & (US$ Million)
Table 105. Europe Androstenedione Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Europe Androstenedione Sales by Country (2018-2023) & (MT)
Table 107. Europe Androstenedione Sales by Country (2024-2029) & (MT)
Table 108. Europe Androstenedione Revenue by Country (2018-2023) & (US$ Million)
Table 109. Europe Androstenedione Revenue by Country (2024-2029) & (US$ Million)
Table 110. Asia Pacific Androstenedione Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Asia Pacific Androstenedione Sales by Country (2018-2023) & (MT)
Table 112. Asia Pacific Androstenedione Sales by Country (2024-2029) & (MT)
Table 113. Asia Pacific Androstenedione Revenue by Country (2018-2023) & (US$ Million)
Table 114. Asia Pacific Androstenedione Revenue by Country (2024-2029) & (US$ Million)
Table 115. Latin America Androstenedione Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Latin America Androstenedione Sales by Country (2018-2023) & (MT)
Table 117. Latin America Androstenedione Sales by Country (2024-2029) & (MT)
Table 118. Latin America Androstenedione Revenue by Country (2018-2023) & (US$ Million)
Table 119. Latin America Androstenedione Revenue by Country (2024-2029) & (US$ Million)
Table 120. Middle East and Africa Androstenedione Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Middle East and Africa Androstenedione Sales by Country (2018-2023) & (MT)
Table 122. Middle East and Africa Androstenedione Sales by Country (2024-2029) & (MT)
Table 123. Middle East and Africa Androstenedione Revenue by Country (2018-2023) & (US$ Million)
Table 124. Middle East and Africa Androstenedione Revenue by Country (2024-2029) & (US$ Million)
Table 125. Global Androstenedione Sales by Type (2018-2023) & (MT)
Table 126. Global Androstenedione Sales by Type (2024-2029) & (MT)
Table 127. Global Androstenedione Sales Market Share by Type (2018-2023)
Table 128. Global Androstenedione Sales Market Share by Type (2024-2029)
Table 129. Global Androstenedione Revenue by Type (2018-2023) & (US$ Million)
Table 130. Global Androstenedione Revenue by Type (2024-2029) & (US$ Million)
Table 131. Global Androstenedione Revenue Market Share by Type (2018-2023)
Table 132. Global Androstenedione Revenue Market Share by Type (2024-2029)
Table 133. Global Androstenedione Price by Type (2018-2023) & (USD/MT)
Table 134. Global Androstenedione Price by Type (2024-2029) & (USD/MT)
Table 135. Global Androstenedione Sales by Application (2018-2023) & (MT)
Table 136. Global Androstenedione Sales by Application (2024-2029) & (MT)
Table 137. Global Androstenedione Sales Market Share by Application (2018-2023)
Table 138. Global Androstenedione Sales Market Share by Application (2024-2029)
Table 139. Global Androstenedione Revenue by Application (2018-2023) & (US$ Million)
Table 140. Global Androstenedione Revenue by Application (2024-2029) & (US$ Million)
Table 141. Global Androstenedione Revenue Market Share by Application (2018-2023)
Table 142. Global Androstenedione Revenue Market Share by Application (2024-2029)
Table 143. Global Androstenedione Price by Application (2018-2023) & (USD/MT)
Table 144. Global Androstenedione Price by Application (2024-2029) & (USD/MT)
Table 145. Key Raw Materials
Table 146. Raw Materials Key Suppliers
Table 147. Androstenedione Distributors List
Table 148. Androstenedione Customers List
Table 149. Androstenedione Industry Trends
Table 150. Androstenedione Industry Drivers
Table 151. Androstenedione Industry Restraints
Table 152. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Androstenedione Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Androstenedione Sales (MT) of Manufacturers (2018-2023)
Table 7. Global Androstenedione Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Androstenedione Revenue of Manufacturers (2018-2023)
Table 9. Global Androstenedione Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Androstenedione Average Price (USD/MT) of Manufacturers (2018-2023)
Table 11. Global Androstenedione Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Androstenedione, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Androstenedione by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. BIOVET Company Information
Table 17. BIOVET Business Overview
Table 18. BIOVET Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 19. BIOVET Androstenedione Product Portfolio
Table 20. BIOVET Recent Developments
Table 21. Indo Phyto Chemicals Company Information
Table 22. Indo Phyto Chemicals Business Overview
Table 23. Indo Phyto Chemicals Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 24. Indo Phyto Chemicals Androstenedione Product Portfolio
Table 25. Indo Phyto Chemicals Recent Developments
Table 26. Sito Bio Company Information
Table 27. Sito Bio Business Overview
Table 28. Sito Bio Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 29. Sito Bio Androstenedione Product Portfolio
Table 30. Sito Bio Recent Developments
Table 31. Goto Pharmaceutical Company Information
Table 32. Goto Pharmaceutical Business Overview
Table 33. Goto Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 34. Goto Pharmaceutical Androstenedione Product Portfolio
Table 35. Goto Pharmaceutical Recent Developments
Table 36. Tianjin King York Company Information
Table 37. Tianjin King York Business Overview
Table 38. Tianjin King York Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 39. Tianjin King York Androstenedione Product Portfolio
Table 40. Tianjin King York Recent Developments
Table 41. Jiufu Company Information
Table 42. Jiufu Business Overview
Table 43. Jiufu Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 44. Jiufu Androstenedione Product Portfolio
Table 45. Jiufu Recent Developments
Table 46. Yongning Pharma Company Information
Table 47. Yongning Pharma Business Overview
Table 48. Yongning Pharma Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 49. Yongning Pharma Androstenedione Product Portfolio
Table 50. Yongning Pharma Recent Developments
Table 51. Jiangxi Hongyuan Pharmaceutical Company Information
Table 52. Jiangxi Hongyuan Pharmaceutical Business Overview
Table 53. Jiangxi Hongyuan Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 54. Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolio
Table 55. Jiangxi Hongyuan Pharmaceutical Recent Developments
Table 56. Kaizon Company Information
Table 57. Kaizon Business Overview
Table 58. Kaizon Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Kaizon Androstenedione Product Portfolio
Table 60. Kaizon Recent Developments
Table 61. Xi’an Gaoyuan Bio-Chem Company Information
Table 62. Xi’an Gaoyuan Bio-Chem Business Overview
Table 63. Xi’an Gaoyuan Bio-Chem Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 64. Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolio
Table 65. Xi’an Gaoyuan Bio-Chem Recent Developments
Table 66. Dongyao Pharmaceutical Company Information
Table 67. Dongyao Pharmaceutical Business Overview
Table 68. Dongyao Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 69. Dongyao Pharmaceutical Androstenedione Product Portfolio
Table 70. Dongyao Pharmaceutical Recent Developments
Table 71. Huazhong Pharmaceutical Company Information
Table 72. Huazhong Pharmaceutical Business Overview
Table 73. Huazhong Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 74. Huazhong Pharmaceutical Androstenedione Product Portfolio
Table 75. Huazhong Pharmaceutical Recent Developments
Table 76. Darui Company Information
Table 77. Darui Business Overview
Table 78. Darui Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 79. Darui Androstenedione Product Portfolio
Table 80. Darui Recent Developments
Table 81. Danjiangkou Danao Company Information
Table 82. Danjiangkou Danao Business Overview
Table 83. Danjiangkou Danao Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 84. Danjiangkou Danao Androstenedione Product Portfolio
Table 85. Danjiangkou Danao Recent Developments
Table 86. Dahua Pharmaceutical Company Information
Table 87. Dahua Pharmaceutical Business Overview
Table 88. Dahua Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 89. Dahua Pharmaceutical Androstenedione Product Portfolio
Table 90. Dahua Pharmaceutical Recent Developments
Table 91. Global Androstenedione Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 92. Global Androstenedione Sales by Region (2018-2023) & (MT)
Table 93. Global Androstenedione Sales Market Share by Region (2018-2023)
Table 94. Global Androstenedione Sales by Region (2024-2029) & (MT)
Table 95. Global Androstenedione Sales Market Share by Region (2024-2029)
Table 96. Global Androstenedione Revenue by Region (2018-2023) & (US$ Million)
Table 97. Global Androstenedione Revenue Market Share by Region (2018-2023)
Table 98. Global Androstenedione Revenue by Region (2024-2029) & (US$ Million)
Table 99. Global Androstenedione Revenue Market Share by Region (2024-2029)
Table 100. North America Androstenedione Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. North America Androstenedione Sales by Country (2018-2023) & (MT)
Table 102. North America Androstenedione Sales by Country (2024-2029) & (MT)
Table 103. North America Androstenedione Revenue by Country (2018-2023) & (US$ Million)
Table 104. North America Androstenedione Revenue by Country (2024-2029) & (US$ Million)
Table 105. Europe Androstenedione Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Europe Androstenedione Sales by Country (2018-2023) & (MT)
Table 107. Europe Androstenedione Sales by Country (2024-2029) & (MT)
Table 108. Europe Androstenedione Revenue by Country (2018-2023) & (US$ Million)
Table 109. Europe Androstenedione Revenue by Country (2024-2029) & (US$ Million)
Table 110. Asia Pacific Androstenedione Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Asia Pacific Androstenedione Sales by Country (2018-2023) & (MT)
Table 112. Asia Pacific Androstenedione Sales by Country (2024-2029) & (MT)
Table 113. Asia Pacific Androstenedione Revenue by Country (2018-2023) & (US$ Million)
Table 114. Asia Pacific Androstenedione Revenue by Country (2024-2029) & (US$ Million)
Table 115. Latin America Androstenedione Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Latin America Androstenedione Sales by Country (2018-2023) & (MT)
Table 117. Latin America Androstenedione Sales by Country (2024-2029) & (MT)
Table 118. Latin America Androstenedione Revenue by Country (2018-2023) & (US$ Million)
Table 119. Latin America Androstenedione Revenue by Country (2024-2029) & (US$ Million)
Table 120. Middle East and Africa Androstenedione Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Middle East and Africa Androstenedione Sales by Country (2018-2023) & (MT)
Table 122. Middle East and Africa Androstenedione Sales by Country (2024-2029) & (MT)
Table 123. Middle East and Africa Androstenedione Revenue by Country (2018-2023) & (US$ Million)
Table 124. Middle East and Africa Androstenedione Revenue by Country (2024-2029) & (US$ Million)
Table 125. Global Androstenedione Sales by Type (2018-2023) & (MT)
Table 126. Global Androstenedione Sales by Type (2024-2029) & (MT)
Table 127. Global Androstenedione Sales Market Share by Type (2018-2023)
Table 128. Global Androstenedione Sales Market Share by Type (2024-2029)
Table 129. Global Androstenedione Revenue by Type (2018-2023) & (US$ Million)
Table 130. Global Androstenedione Revenue by Type (2024-2029) & (US$ Million)
Table 131. Global Androstenedione Revenue Market Share by Type (2018-2023)
Table 132. Global Androstenedione Revenue Market Share by Type (2024-2029)
Table 133. Global Androstenedione Price by Type (2018-2023) & (USD/MT)
Table 134. Global Androstenedione Price by Type (2024-2029) & (USD/MT)
Table 135. Global Androstenedione Sales by Application (2018-2023) & (MT)
Table 136. Global Androstenedione Sales by Application (2024-2029) & (MT)
Table 137. Global Androstenedione Sales Market Share by Application (2018-2023)
Table 138. Global Androstenedione Sales Market Share by Application (2024-2029)
Table 139. Global Androstenedione Revenue by Application (2018-2023) & (US$ Million)
Table 140. Global Androstenedione Revenue by Application (2024-2029) & (US$ Million)
Table 141. Global Androstenedione Revenue Market Share by Application (2018-2023)
Table 142. Global Androstenedione Revenue Market Share by Application (2024-2029)
Table 143. Global Androstenedione Price by Application (2018-2023) & (USD/MT)
Table 144. Global Androstenedione Price by Application (2024-2029) & (USD/MT)
Table 145. Key Raw Materials
Table 146. Raw Materials Key Suppliers
Table 147. Androstenedione Distributors List
Table 148. Androstenedione Customers List
Table 149. Androstenedione Industry Trends
Table 150. Androstenedione Industry Drivers
Table 151. Androstenedione Industry Restraints
Table 152. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. AndrostenedioneProduct Picture
Figure 5. Global Androstenedione Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Androstenedione Market Size (2018-2029) & (US$ Million)
Figure 7. Global Androstenedione Sales (2018-2029) & (MT)
Figure 8. Global Androstenedione Average Price (USD/MT) & (2018-2029)
Figure 9. Androstenedione Product Picture
Figure 10. Androstadienedione Product Picture
Figure 11. Arthritis Pharmaceuticals Product Picture
Figure 12. Fertility Control Pharmaceuticals Product Picture
Figure 13. Infectious Inflammation Pharmaceuticals Product Picture
Figure 14. Others Product Picture
Figure 15. Global Androstenedione Revenue Share by Manufacturers in 2022
Figure 16. Global Manufacturers of Androstenedione, Manufacturing Sites & Headquarters
Figure 17. Global Manufacturers of Androstenedione, Date of Enter into This Industry
Figure 18. Global Top 5 and 10 Androstenedione Players Market Share by Revenue in 2022
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 20. Global Androstenedione Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. Global Androstenedione Sales by Region in 2022
Figure 22. Global Androstenedione Revenue by Region in 2022
Figure 23. North America Androstenedione Market Size by Country in 2022
Figure 24. North America Androstenedione Sales Market Share by Country (2018-2029)
Figure 25. North America Androstenedione Revenue Market Share by Country (2018-2029)
Figure 26. U.S. Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Androstenedione Market Size by Country in 2022
Figure 29. Europe Androstenedione Sales Market Share by Country (2018-2029)
Figure 30. Europe Androstenedione Revenue Market Share by Country (2018-2029)
Figure 31. Germany Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Androstenedione Market Size by Country in 2022
Figure 37. Asia Pacific Androstenedione Sales Market Share by Country (2018-2029)
Figure 38. Asia Pacific Androstenedione Revenue Market Share by Country (2018-2029)
Figure 39. China Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. China Taiwan Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Androstenedione Market Size by Country in 2022
Figure 49. Latin America Androstenedione Sales Market Share by Country (2018-2029)
Figure 50. Latin America Androstenedione Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East and Africa Androstenedione Market Size by Country in 2022
Figure 55. Middle East and Africa Androstenedione Sales Market Share by Country (2018-2029)
Figure 56. Middle East and Africa Androstenedione Revenue Market Share by Country (2018-2029)
Figure 57. Turkey Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. UAE Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Global Androstenedione Sales Market Share by Type (2018-2029)
Figure 61. Global Androstenedione Revenue Market Share by Type (2018-2029)
Figure 62. Global Androstenedione Price (USD/MT) by Type (2018-2029)
Figure 63. Global Androstenedione Sales Market Share by Application (2018-2029)
Figure 64. Global Androstenedione Revenue Market Share by Application (2018-2029)
Figure 65. Global Androstenedione Price (USD/MT) by Application (2018-2029)
Figure 66. Androstenedione Value Chain
Figure 67. Androstenedione Production Mode & Process
Figure 68. Direct Comparison with Distribution Share
Figure 69. Distributors Profiles
Figure 70. Androstenedione Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. AndrostenedioneProduct Picture
Figure 5. Global Androstenedione Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Androstenedione Market Size (2018-2029) & (US$ Million)
Figure 7. Global Androstenedione Sales (2018-2029) & (MT)
Figure 8. Global Androstenedione Average Price (USD/MT) & (2018-2029)
Figure 9. Androstenedione Product Picture
Figure 10. Androstadienedione Product Picture
Figure 11. Arthritis Pharmaceuticals Product Picture
Figure 12. Fertility Control Pharmaceuticals Product Picture
Figure 13. Infectious Inflammation Pharmaceuticals Product Picture
Figure 14. Others Product Picture
Figure 15. Global Androstenedione Revenue Share by Manufacturers in 2022
Figure 16. Global Manufacturers of Androstenedione, Manufacturing Sites & Headquarters
Figure 17. Global Manufacturers of Androstenedione, Date of Enter into This Industry
Figure 18. Global Top 5 and 10 Androstenedione Players Market Share by Revenue in 2022
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 20. Global Androstenedione Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. Global Androstenedione Sales by Region in 2022
Figure 22. Global Androstenedione Revenue by Region in 2022
Figure 23. North America Androstenedione Market Size by Country in 2022
Figure 24. North America Androstenedione Sales Market Share by Country (2018-2029)
Figure 25. North America Androstenedione Revenue Market Share by Country (2018-2029)
Figure 26. U.S. Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Androstenedione Market Size by Country in 2022
Figure 29. Europe Androstenedione Sales Market Share by Country (2018-2029)
Figure 30. Europe Androstenedione Revenue Market Share by Country (2018-2029)
Figure 31. Germany Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Androstenedione Market Size by Country in 2022
Figure 37. Asia Pacific Androstenedione Sales Market Share by Country (2018-2029)
Figure 38. Asia Pacific Androstenedione Revenue Market Share by Country (2018-2029)
Figure 39. China Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. China Taiwan Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Androstenedione Market Size by Country in 2022
Figure 49. Latin America Androstenedione Sales Market Share by Country (2018-2029)
Figure 50. Latin America Androstenedione Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East and Africa Androstenedione Market Size by Country in 2022
Figure 55. Middle East and Africa Androstenedione Sales Market Share by Country (2018-2029)
Figure 56. Middle East and Africa Androstenedione Revenue Market Share by Country (2018-2029)
Figure 57. Turkey Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. UAE Androstenedione Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Global Androstenedione Sales Market Share by Type (2018-2029)
Figure 61. Global Androstenedione Revenue Market Share by Type (2018-2029)
Figure 62. Global Androstenedione Price (USD/MT) by Type (2018-2029)
Figure 63. Global Androstenedione Sales Market Share by Application (2018-2029)
Figure 64. Global Androstenedione Revenue Market Share by Application (2018-2029)
Figure 65. Global Androstenedione Price (USD/MT) by Application (2018-2029)
Figure 66. Androstenedione Value Chain
Figure 67. Androstenedione Production Mode & Process
Figure 68. Direct Comparison with Distribution Share
Figure 69. Distributors Profiles
Figure 70. Androstenedione Industry Opportunities and Challenges
